BOSTON PHARMATECH Trademark
Trademark Overview
On Thursday, January 5, 2023, a trademark application was filed for BOSTON PHARMATECH with the United States Patent and Trademark Office. The USPTO has given the BOSTON PHARMATECH trademark a serial number of 97742417. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Friday, January 10, 2025. This trademark is owned by Boston Pharmatech, LLC. The BOSTON PHARMATECH trademark is filed in the Pharmaceutical Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:
Dietary supplements
Medical and pharmaceutical consultation
Consulting services in the field of pharmaceutical research and development
General Information
| Serial Number | 97742417 |
| Word Mark | BOSTON PHARMATECH |
| Filing Date | Thursday, January 5, 2023 |
| Status | 641 - NON-FINAL ACTION - MAILED |
| Status Date | Friday, January 10, 2025 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 5 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
| Published for Opposition Date | NOT AVAILABLE |
Trademark Statements
| Description of Mark | The mark consists of the company name and blended initials that are superimposed. |
| Goods and Services | Dietary supplements |
| Goods and Services | Medical and pharmaceutical consultation |
| NOT AVAILABLE | "BOSTON" |
| Goods and Services | Consulting services in the field of pharmaceutical research and development |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, January 29, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | Tuesday, May 3, 2016 |
| First Use In Commerce Date | Tuesday, May 3, 2016 |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, January 29, 2023 |
| Primary Code | 042 |
| First Use Anywhere Date | Tuesday, May 3, 2016 |
| First Use In Commerce Date | Tuesday, May 3, 2016 |
| International Class | 044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Sunday, January 29, 2023 |
| Primary Code | 044 |
| First Use Anywhere Date | Tuesday, May 3, 2016 |
| First Use In Commerce Date | Tuesday, May 3, 2016 |
Trademark Owner History
| Party Name | Boston Pharmatech, LLC |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 16 - Limited Liability Company |
| Address | Natick, MA 01760 |
Trademark Events
| Event Date | Event Description |
| Monday, January 9, 2023 | NEW APPLICATION ENTERED |
| Sunday, January 29, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, September 28, 2023 | ASSIGNED TO EXAMINER |
| Friday, September 29, 2023 | NON-FINAL ACTION WRITTEN |
| Friday, September 29, 2023 | NON-FINAL ACTION E-MAILED |
| Friday, September 29, 2023 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Tuesday, November 14, 2023 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Thursday, April 4, 2024 | ASSIGNED TO LIE |
| Friday, April 5, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 5, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, January 10, 2025 | NON-FINAL ACTION WRITTEN |
| Friday, January 10, 2025 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Friday, January 10, 2025 | NON-FINAL ACTION E-MAILED |
